WHAT SHE SAID RADIO (SIRIUSXM)
There are still far too many myths and misconceptions surrounding medical cannabis. On Tuesday, Dr. Catherine Jacobson, the Director of Clinical Research at Tilray, appeared on What She Said Radio to debunk those myths and answer some frequently asked questions.
CTV VANCOUVER ISLAND
Tilray, one of Canada's largest medical marijuana producers, has opened the doors of its 65,000-square-foot, $30-million Nanaimo facility to give a rare glimpse of its production process. Company CEO Greg Engel answers five questions about the facility, its employees, legalization, and lessons for the industry.
WASHINGTON POST
Brendan Kennedy, president of Privateer Holdings of Seattle, welcomed the Canadian announcement. His company owns Tilray, a medicinal marijuana facility in British Columbia, and he is looking to build a facility that would supply the market for recreational marijuana in Canada.
THE GUARDIAN
As a mother, I am furious that the federal government has discouraged research into these potentially life-saving therapies for years by restricting clinical research. As a scientist, I decry the federal government for interfering with scientific freedom.
NATIONAL POST
These seismic global shifts in perception and policy have a deeply personal significance for me. As a scientist and director of clinical research at Tilray, one of Canada’s largest producers of medical cannabis, I welcome policies that open the doors for ground-breaking and potentially life-saving research.
NEWS.COM.AU
Earlier this month, the global president of Canadian firm Tilray predicted medical marijuana had the potential to be a billion-dollar industry in Australia and create thousands of skilled jobs.
ABC NEWS AUSTRALIA
Medical cannabis is a US$10b market that will grow to $100b over next 3 to 5 years, that's according to Brendan Kennedy, global president of Tilray, one of the largest producers of the product. Tilray is owned by US private equity firm Privateer Holdings. Last week the Australian senate passed legislation to allow the growing of medical cannabis.
AUSTRALIAN BROADCASTING CORPORATION
The largest clinical trial of its kind, testing medicinal cannabis to treat chemotherapy patients suffering from nausea, has been announced by New South Wales Premier Mike Baird. About 330 patients are expected to take part in the clinical trial which will use a cannabis-derived tablet manufactured by Canadian company Tilray.
SYDNEY MORNING HERALD
A Canadian pharmaceutical company, Tilray, will supply the trial with specially-prepared tablets that contain marijuana extracts that maximise the drug's anti-nausea properties and minimise its psychoactive effects.
THE GLOBE AND MAIL
Philippe Lucas, executive director of the council, said he met with a policy adviser to Finance Minister Bill Morneau during prebudget consultations last week. His group represents Tilray, Peace Naturals and Delta 9 Bio-Tech, which are among about two dozen commercial producers licensed to ship medical marijuana to patients through the mail.
CALGARY HERALD
The operation on Vancouver Island has been shipping BC-grown medical marijuana to Canadian patients for whom it has been prescribed since April 28, 2014.
THE GLOBE AND MAIL
What we continue to hear from government, both at the provincial and federal level, is they are very focused on ensuring a high level of control and quality on the production of cannabis for the adult recreational space, and we are very supportive of that,” said Greg Engel, chief executive of Tilray, which has been a licensed producer for nearly two years.
THE GLOBE AND MAIL
“What we continue to hear from government, both at the provincial and federal level, is they are very focused on ensuring a high level of control and quality on the production of cannabis for the adult recreational space, and we are very supportive of that,” said Greg Engel, chief executive of Tilray, which has been a licensed producer for nearly two years.
VANCOUVER SUN
A B.C. company licensed by Health Canada could be involved in the first Canadian trial of CBD oil and epilepsy in adults. Nanaimo-based Tilray will provide CBD oil capsules to a team working with the Ontario Brain Institute.
THE GLOBE AND MAIL
Growers Aphria, Emerald Health Botanicals, MedReleaf, The Peace Naturals Project and Tilray helped sponsor this week’s event.
CTV NEWS
Tilray announced Monday that it has 20 cannabis extract products awaiting Health Canada approval, including oils in liquid form, gel caps and a topical preparation for certain skin conditions.
NATIONAL POST
A number of Canada’s medical marijuana growers are poised to release cannabis oils for authorized patients who don’t want to smoke or vaporize the dried herb to relieve their symptoms.
METRO NEWS
Nanaimo-based Tilray, one of Canada’s 26 licensed medical marijuana producers, wants to start selling oils and extracts. It still needs Health Canada approval.
CTV NEWS
An Alberta mother whose daughter has severe epilepsy has travelled to Ontario for a medical marijuana prescription after the girl's doctor said he was no longer allowed to provide permission to purchase the product.
THE GLOBE AND MAIL
An Alberta mother whose daughter has severe epilepsy has travelled to Ontario for a medical marijuana prescription after the girl’s doctor said he was no longer allowed to provide permission to purchase the product.
